BCR::ABL1 fusion is a genetic hallmark of chronic myeloid leukemia (CML) and is found in approximately 20%–50% of adult patients with acute lymphoblastic leukemia (ALL) [1]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.